首页 | 本学科首页   官方微博 | 高级检索  
检索        

霉酚酸酯在肾移植患者中的应用
引用本文:徐红冰,寿佳慧,归成,陶亚菊,李灿明.霉酚酸酯在肾移植患者中的应用[J].中国临床药学杂志,2001,10(3):153-155.
作者姓名:徐红冰  寿佳慧  归成  陶亚菊  李灿明
作者单位:1. 上海市第一人民医院药剂科
2. 上海市第一人民医院肾移植科
摘    要:目的:将免疫抑制剂霉酚酸酯(MMF)在预防肾移植术后的排斥反应及肝毒性发生率等指标与硫唑嘌呤(Aza)进行临床对照观察。方法:MMF组(环孢素A+泼尼松+MMF)35例,对照组(环孢素A+泼尼松+Aza)25例。试验观察期24mo。结果:MMF组移植术后排斥反应及肝毒性发生率明显低于对照组,2组差异有高度统计学意义(P肝<0.01,P肾<0.01);且MMF组肾功能较对照组平稳。结论:MMF与环孢素A及泼尼松三药联用,可降低急慢性排斥反应及肝肾毒性发生率,从而提高了免疫抑制剂应用的安全性和耐受性。

关 键 词:霉酚酸酯  硫唑嘌呤  环孢素A  排斥反应  肝毒性  CsA  MMF
文章编号:1007-4406(2001)03-0153-03

Application of mycophenolate mofetil in renal transplantation patients
Xu Hongbing ,Shou Jiahui ,Gui Cheng ,Tao Yaju ,Li Canming.Application of mycophenolate mofetil in renal transplantation patients[J].Chinese Journal of Clinical Pharmacy,2001,10(3):153-155.
Authors:Xu Hongbing  Shou Jiahui  Gui Cheng  Tao Yaju  Li Canming
Institution:Xu Hongbing 1,Shou Jiahui 1,Gui Cheng 1,Tao Yaju 1,Li Canming 2
Abstract:AIM: To compare the effects of the immunoinhibition of mycophenolate mofetil (MMF) between MMF group and control group. METHODS: The renal transplantation patients were divided into 2 groups: MMF group (cyclosporin A+prednisone+MMF); control group (cyclosporin A+prednisone+Azathioprine), the 2 groups were studied for 2 y. RESULTS: The incidence of acute rejection and hepatic toxicity of MMF group were belower to control group obviously ( P <0 01). CONCLUSION: MMF group (cyclosporin A+prednisone+MMF) may reduce incidence of acute rejection and hepatic toxicity, and improve safety of immunoinhibitor.
Keywords:mycophenolate mofetil  azathioprine  cyclosporin A  rejection  hepatic toxicity
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号